Maravai anticipates $185M 2025 revenue and $10M-$20M annual COVID CleanCap sales as cost actions progress
Source: SeekingAlpha
2025-11-06 23:26:51 ET
More on Maravai LifeSciences Holdings
- Maravai LifeSciences Holdings, Inc. (MRVI) Q3 2025 Earnings Call Transcript
- Maravai LifeSciences Holdings, Inc. 2025 Q3 - Results - Earnings Call Presentation
- Maravai LifeSciences Holdings, Inc. (MRVI) Q2 2025 Earnings Call Transcript
- Maravai LifeSciences Holdings Q3 2025 Earnings Preview
- Goldman's 48 potential M&A candidates
Read the full article on Seeking Alpha
For further details see:
Maravai anticipates $185M 2025 revenue and $10M–$20M annual COVID CleanCap sales as cost actions progress
Maravai LifeSciences Holdings Inc.
NASDAQ: MRVI
MRVI Trading
-5.25% G/L:
$3.25 Last:
280,583 Volume:
$3.30 Open:
MRVI Latest News
February 25, 2026 04:01:00 pm
Maravai Lifesciences Reports Fourth Quarter and Full Year 2025 Financial Results
February 09, 2026 05:05:00 pm
Maravai LifeSciences To Host Earnings Conference Call on Wednesday, February 25, 2026
November 10, 2025 08:00:00 am
Maravai LifeSciences Announces November 2025 Investor Conference Schedule
MRVI Stock Data
$793,969,710
250,311,417
0.18%
50
N/A
Biotechnology & Life Sciences
Healthcare
US
San Diego
